Actively Recruiting
Efficacy of rTMS Treatment After Spinal Cord Injury
Led by Oslo University Hospital · Updated on 2024-06-18
20
Participants Needed
1
Research Sites
293 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
There is accumulating evidence that neuromodulation by repetitive transcranial magnetic stimulation (rTMS) of the motor cortex holds promise as a treatment for rehabilitation of motor function following a spinal cord injury. This study is designed to assess the clinical potential of non-invasive stimulation of the primary motor cortex to improve motor functions.The results will help to evaluate the clinical relevance of motor cortex stimulation for motor functions in patients with spinal cord injury. The outcomes of this study could potentially support the initiation of a larger clinical trial and the development of a new routine treatment.
CONDITIONS
Official Title
Efficacy of rTMS Treatment After Spinal Cord Injury
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age over 18 years and less than 80 years
- Chronic incomplete cervical and/or thoracic spinal cord injury (C4-T12) classified as ASIA C or D
- Able and willing to give informed consent and follow the treatment schedule
- Able to be followed for the entire study duration
You will not qualify if you...
- Contraindications to rTMS including past severe head trauma, history of epilepsy, active brain tumor, or intracranial hypertension
- Presence of implanted ferromagnetic devices such as pacemakers, neurostimulators, or cochlear implants
- Pregnancy or breastfeeding
- Any significant or unstable medical or psychiatric condition
- Participation in other research protocols recently or currently
- History of Deep Brain Stimulation treatment
- Legal guardianship or tutelage status
- History of substance abuse (alcohol or drugs)
- Pending legal litigation
- Inability to understand the study or complete forms
- Chronic use of sedative medication
- Participation in another spinal cord injury clinical trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oslo University Hospital - Rikshospitalet
Oslo, Norway, 0372
Actively Recruiting
Research Team
M
Mark Züchner, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here